AYAlyssa Yeager

Alyssa Yeager

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alyssa Yeager has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intervention to Improve Performance of Antimicrobial Automatic Stop Orders

    by Alyssa Yeager, Yevgeniy Gitelman, Steven Morgan, Jillian Dougherty, Daniel Timko, Shawn Binkley, Keith Hamilton

    Background. Antimicrobial stewardship programs (ASP) have been shown to decrease inappropriate antibiotic use, improve patient outcomes, and decrease antimicrobial resistance. Automatic stop orders (ASO) of antimicrobial medications have been recommended as a component of ASPs and have been shown to reduce duration of therapy. However, some studies have revealed that ASOs can unintentionally discontinue or interrupt treatment. In our health system, which uses 7-day antimicrobial ASO, the ASP teams introduced a multifaceted intervention, which included increasing visibility of prophylactic antibiotic orders with a 90-day ASO and implementing a prospective review of all antimicrobials that expired by ASO using a novel electronic dashboard.

  • CanSupport: a model for home-based palliative care delivery in India

    by Alyssa Yeager, Anna W. LaVigne, Ambika Rajvanshi, Birbal Mahato, Ravinder Mohan, Reena Sharma, Surbhi Grover

    Background: According to the 2014 WHO Global Atlas of Palliative Care, there is insufficient access to palliative care services worldwide, with the majority of unmet need in low- and middle-income countries. In India, there are major disparities in access to palliative care, with the majority of services being offered by non-governmental organizations (NGOs) scattered throughout the country. The barriers to expanding palliative care services in India are common to many lower- and middle-income countries—a lack of financial resources, a paucity of trained staff, and a focus on curative rather than comfort care. In this paper, we describe a model of palliative care being used by CanSupport, a non-governmental organization based in Delhi that was formed in 1996. They offer home-based services provided by multidisciplinary teams consisting of a physician, nurse, and social worker who are trained in palliative care. Methods: Data on patient demographics, services provided, and outcomes were collected retrospectively for patients treated by CanSupport for the year 2009–2010. Sources include CanSupport’s population data and direct discussions with CanSupport staff. Results: During the year 2009–2010, CanSupport served 746 patients, with an average of 10 home visits per patient. Only 29% of patients were referred from hospitals or physicians, with the rest being self-referred or referred from CanSupport’s help line. Pain scales were administered on each visit and 31% of patients received morphine. Of the 514 patient deaths, 76% occurred at home and a majority of families received bereavement counseling for up to 6 months. Conclusions: CanSupport has shown that a home-based care model can be successful in India and is desired by patients at the end of life or with chronic illness. Their model of care saves the patients the cost of a hospital visit while still providing evaluation by staff with training in palliative care. In addition, the multidisciplinary nature of the teams allows for symptom management and emotional counseling for both the patients and their families. CanSupport has developed a way to provide reliable, cost-effective palliative care to patients that can serve as a model for building palliative care capacity in low- and middle-income countries.


  • Open Access

    Unilateral Axillary Toxic Erythema of Chemotherapy in a Patient With Previous Axillary Lymph Node Dissection

    by Alyssa Yeager, Sasha Stephen, Amy Forrestel, Misha Rosenbach

    Case Report from JAMA Dermatology — Unilateral Axillary Toxic Erythema of Chemotherapy in a Patient With Previous Axillary Lymph Node Dissection — Implications for Pathophysiology and Therapy


  • Treatment completion and tolerability of women with cervical cancer with and without HIV in Botswana.

    by Surbhi Grover, Memory Fadziso Bvochora-Nsingo, Emily MacDuffie, Sarah Ratcliffe, E. Paul Wileyto, Rohini Bhatia, Alyssa Yeager, Sebathu Phillip Chiyapo, Ponatshego A Gaolebale, Anthony Henry Russell, et al.

    5526 Background: Cervical cancer is the leading cause of cancer death for women in Sub-Saharan Africa. HIV increases risk for cervical cancer and concurrent antiretroviral treatment (ART) could increase risk for toxicity of chemoradiation. In the current analysis, we aim to identify differences in treatment toxicities and completion between HIV+ vs. HIV- cervical cancer patients in Botswana treated with radiotherapy (RT). Methods: We prospectively enrolled cervical cancer patients treated with curative RT (+/- chemotherapy). Patients were seen weekly for toxicity monitoring using CTCAE 4 grading. Treatment completion was defined as receiving full dose external beam RT and brachytherapy as prescribed and 4 weekly cycles of cisplatin in < 8 weeks. Results: 190 women were enrolled between 7/2013 and 1/2015. 181 women with complete treatment and HIV data were included in the analysis. 66% (121) of women were HIV+ and presented at a younger age compared to HIV- (median 44 vs. 56 years; p<0.001) and at an earlier stage (HIV- 39% stage II and 47% stage III vs. HIV+ 55% stage II and 31% stage III, p=0.02). Median CD4 count for HIV+ was 469 (range 118-941). 94% of HIV+ patients were on ART. There were no differences between HIV+ vs. HIV- in treatment received and toxicities except renal toxicity in univariate analyses. Only 25% HIV+ vs. 28% HIV- completed treatment. See Table 1. Conclusions: The majority of cervical cancer patients in Botswana are women with well-controlled HIV infection. No significant differences were detected in treatment completion, but HIV+ patients seemed to be at increased risk of renal toxicity. We are further exploring reasons for poor treatment completion in both groups.

  • Open Access

    A Systematic Review of Radiotherapy Capacity in Low- and Middle-Income Countries

    by Surbhi Grover, Melody J. Xu, Alyssa Yeager, Lori Rosman, Reinou S. Groen, Smita Chackungal, Danielle Rodin, Margaret Mangaali, Sommer Nurkic, Annemarie Fernandes, et al.

    Objectives: The cancer burden in Low and Middle Income Countries (LMIC) is substantial. The purpose of this study was to identify and describe country and region-specific patterns of radiotherapy (RT) facilities in LMIC. Methods: A systematic review of the literature was undertaken. A search strategy was developed to include articles on radiation capacity in LMIC from the following databases: PubMed, Embase, CINAHL Plus, Global Health and the Latin-American and Caribbean System on Health Sciences Information. Searches included all literature up to April 2013. Results: A total of 49 articles were included in the review. Studies reviewed were divided into one of four regions: Africa, Asia, Eastern Europe, and South America. The African continent has the least amount of resources for RT. Furthermore, a wide disparity exists, as 60% of all machines on the continent are concentrated in Egypt and South Africa while 29 countries in Africa are still lacking any RT resource. A significant heterogeneity also exists across Southeast Asia despite a three-fold increase in megavoltage teletherapy machines from 1976 to 1999, which corresponds with a rise in economic status. In LMIC of the Americas, only Uruguay met the International Atomic Energy Agency (IAEA) recommendations of 4 MV/million population, whereas Bolivia and Venezuela had the most radiation oncologists (>1 per 1000 new cancer cases). The main concern with the review of RT resources in Eastern Europe was the lack of data. Conclusions: There is a dearth of publications on RT therapy infrastructure in LMIC. However, based on limited published data, availability of RT resources reflects the economic status of the countries. The challenges to delivering radiation in the discussed regions are multidimensional and include: lack of physical resources, lack of human personnel, and lack of data. Furthermore, access to existing radiotherapy and affordability of care remains a large problem.


  • Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage

    by Daniel J. Colacurcio, Alyssa Yeager, Dennis L. Kolson, Kelly L. Jordan-Sciutto, Cagla Akay


  • Computerized Virtual Surgery Demonstrates Where Acetabular Rim Osteophytes Most Reduce Range of Motion following Total Hip Arthroplasty

    by Sebastian Rodriguez-Elizalde, Alyssa M. Yeager, Bheeshma Ravi, Joseph D. Lipman, Eduardo A. Salvati, Geoffrey H. Westrich

    Acetabular osteophytes are common findings during total hip arthroplasty (THA). This study was designed to determine the extent to which osteophytes may limit range of motion (ROM) and in which locations impingement is likely to occur if osteophytes are not removed during surgery. Computer-aided design was used to compare ROM of a modern hip implant in four cadaver models with and without 10-mm acetabular rim osteophytes added. A clock face, with 12 o’clock at the superior pole of the right acetabulum, was used to map impingement. The osteophyte model limited ROM in flexion (101° v. 113°, p = 0.03), 90° of flexion with internal rotation (16.7° v. 31.6°, p = 0.01), and external rotation (30.4° v. 49.5°, p = 0.01). Impingement occurred between 7 and 8 o’clock in external rotation and 1 and 2 o’clock in the other two motions. Osteophytes in these positions have the greatest impact on ROM and should be removed during THA.